| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da0ce34460c654b33b5d997a7a57ceb1 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02W90-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-04 |
| filingDate |
2009-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3416bd460e308a45cf4bbef02b8ff91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce47c67c4a5a5a738b345f7d767a571b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c3fe5ad03aaa760e385f48f71b41b67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df9302e6bb9736b13eb4baf6c9dbe11b |
| publicationDate |
2010-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
UY-32054-A |
| titleOfInvention |
STABLE SOLID FORMULATION OF A GC-C RECEIVER AGONIST POLYPEPTIDE FOR ORAL ADMINISTRATION. |
| abstract |
Stable solid formulations of linaclotide suitable for oral administration as well as methods for preparing such formulations are described herein. The formulations described herein contain a polypeptide consisting of the amino acid sequence Cys Glu Tyr Cys Asn Pro Ala Cys Thr Gly Cys Tyr ("linaclotide") or a pharmaceutically acceptable salt thereof. The linaclotide formulations described herein are stable and have sufficient shelf life to manufacture, store and distribute the drug. |
| priorityDate |
2008-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |